期刊文献+

茵陈五苓散对代谢综合征患者血清炎症指标的影响 被引量:6

Influence of Yinchen Wuling powder on serum inflammation indexes of metabolic syndrome
暂未订购
导出
摘要 目的:探讨代谢综合征(MS)患者血清炎症标志物的变化及茵陈五苓散治疗对该指标的影响。方法:筛选46例MS患者为观察组,35例年龄、性别相匹配的健康者为对照组,观察两组血清C反应蛋白(hs-CRP)、白介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平变化。46例MS患者采用茵陈五苓散治疗12周,观察治疗前后临床特征与血清hs-CRPI、L-6和TNF-α水平变化。结果:MS患者存在明显的炎症状态,血清hs-CRP、IL-6和TNF-α水平明显升高;治疗12周后,三酰甘油(TG)水平与2 h血糖(2hPG)降低,血清hs-CRPI、L-6和TNF-α水平明显降低。结论:MS患者存在明显的非特异性炎症状态,茵陈五苓散治疗可以缓解炎症,减轻胰岛素抵抗。
出处 《山东中医杂志》 2007年第1期16-18,共3页 Shandong Journal of Traditional Chinese Medicine
基金 广东省中医药管理局资助项目(编号1050007)
  • 相关文献

参考文献10

  • 1[1]Eckle RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365(9 468):1 415.
  • 2[2]Reynolds K,He J.Epidemiology of the metabolic syndrome[J].Am J Med Sci,2005,330(6):273.
  • 3[3]Eckle RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365(9 468):1 415.
  • 4中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3089
  • 5[5]Hotamisligil GS.Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes[J].Diabetes,2005,54(2):73.
  • 6宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:620
  • 7[7]Muller S,Martin S,Koenig W,et al.Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors[J].Diabetologia,2002,45 (3):805.
  • 8[8]Ogihara T,Asano T,Katagiri H,et al.Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase[J].Diabetologia,2004,47 (5):794.
  • 9冯琴,胡义扬.胰岛素抵抗的中医病机证候特点[J].中西医结合学报,2005,3(1):63-65. 被引量:22
  • 10仝小林,段军.代谢综合征的中医认识和治疗[J].中日友好医院学报,2002,16(5):347-348. 被引量:132

二级参考文献54

  • 1吴启锋,熊尚全,温茂详,杨永东,兰东辉.高血压病中医证型与盐敏感性及胰岛素抵抗关系临床研究[J].福建中医药,2002,33(3):3-4. 被引量:38
  • 2吴向明,周守藩.胰岛素抵抗与心血管病[J].心血管病学进展,1994,15(4):215-217. 被引量:20
  • 3熊曼琪,林安钟,朱章志,蔡文就,郑高飞,钟春宁,陈芝喜,贾可亮,沈穗婷,何敏.加味桃核承气汤对Ⅱ型糖尿病大鼠胰岛素抵抗的影响[J].中国中西医结合杂志,1997,17(3):165-168. 被引量:127
  • 4Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease[J]. N Engl J Med, 1996, 334(15):952-957.
  • 5Reaven GM. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia,and coronary heart disease[J]. Am Heart J, 1991, 121(4 Pt 2): 1283-1288.
  • 6DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary heart disease: a complex metabolic web [J].J Cardiovasc Pharmacol, 1992, 20 (Suppl 11): S1-S16.
  • 7Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 8Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 9Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 10Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.

共引文献3734

同被引文献67

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部